Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022

Summiya Nizamuddin*, Ejaz Ahmed Khan, Marie Anne Chattaway, Gauri Godbole

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Abstract

Salmonella Typhi infection in a patient in Pakistan initially responded to standard treatment but failed to respond to subsequent treatment. The first strain was susceptible to carbapenems and azithromycin; subsequent strains harbored the NDM-5 gene. Treatment with a combination of intravenous meropenem and colistin was successful. Carbapenem-resistant Salmonella Typhi emergence will hinder treatment.

Original languageEnglish
Pages (from-to)2395-2397
Number of pages3
JournalEmerging Infectious Diseases
Volume29
Issue number11
DOIs
Publication statusPublished - Nov 2023

Bibliographical note

Publisher Copyright:
© 2023 Centers for Disease Control and Prevention (CDC). All rights reserved.

Fingerprint

Dive into the research topics of 'Case of Carbapenem-Resistant Salmonella Typhi Infection, Pakistan, 2022'. Together they form a unique fingerprint.

Cite this